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Abstract. 
 
The proteoglycan agrin is required for
postsynaptic differentiation at the skeletal neuromus-
cular junction, but is also associated with basal laminae
in numerous other tissues, and with the surfaces of
some neurons. Little is known about its roles at sites
other than the neuromuscular junction, or about how
its expression and subcellular localization are regulated
in any tissue. Here we demonstrate that the murine
 
agrin gene generates two proteins with different NH
 
2
 
termini, and present evidence that these isoforms differ
in subcellular localization, tissue distribution, and func-
 
tion. The two isoforms share 
 
z
 
1,900 amino acids (aa) of
common sequence following unique NH
 
2
 
 termini of 49
or 150 aa; we therefore call them short NH
 
2
 
-terminal
(SN) and long NH
 
2
 
-terminal (LN) isoforms. In the
mouse genome, LN-speciﬁc exons are upstream of an
SN-speciﬁc exon, which is in turn upstream of common
exons. LN-agrin is expressed in both neural and non-
neural tissues. In spinal cord it is expressed in discrete
subsets of cells, including motoneurons. In contrast, SN-
agrin is selectively expressed in the nervous system but
is widely distributed in many neuronal cell types. Both
isoforms are externalized from cells but LN-agrin as-
sembles into basal laminae whereas SN-agrin remains
 
cell associated. Differential expression of the two
isoforms appears to be transcriptionally regulated,
whereas the unique SN and LN sequences direct their
distinct subcellular localizations. Insertion of a “gene
trap” construct into the mouse genome between the LN
and SN exons abolished expression of LN-agrin with no
detectable effect on expression levels of SN-agrin or on
SN-agrin bioactivity in vitro. Agrin protein was absent
from all basal laminae in mice lacking LN-agrin tran-
scripts. The formation of the neuromuscular junctions
was as drastically impaired in these mutants as in mice
lacking all forms of agrin. Thus, basal lamina–associated
 
LN-agrin is required for neuromuscular synaptogene-
sis, whereas cell-associated SN-agrin may play distinct
roles in the central nervous system.
Key words: basal lamina • gene trap • motoneuron •
neuromuscular junction • proteoglycan
 
Introduction
 
Agrin is a heparan sulfate proteoglycan that was purified
 
from basal lamina (BL)
 
1
 
 based upon its ability to induce
clustering of acetylcholine receptors on cultured myotubes
(McMahan, 1990). It has since been shown to be a critical
motoneuron-derived organizer of synaptic differentiation
at the neuromuscular junction in vivo (Gautam et al., 1996;
Cohen et al., 1997a; Meier et al., 1997; Burgess et al.,
1999). However, its broad expression pattern suggests that
it may play additional roles. For example, agrin is synthe-
sized by many neuronal types in addition to motoneurons,
as well as by some glial cells (Hoch et al., 1993; O’Connor
et al., 1994; Ma et al., 1995; Stone and Nikolics, 1995; Co-
hen et al., 1997b). In neurons, it has been localized to both
synapses and neurites (Escher et al., 1996; Mann and
Kroger, 1996; Halfter et al., 1997; Koulen et al., 1999) and
has been shown to affect synthesis and phosphorylation of
transcriptional regulators when applied to cultured neu-
rons (Ji et al., 1998; Hilgenberg et al., 1999). In addition,
agrin is present in distinct subsets of BLs in numerous
nonneural tissues. In kidney, it is a major proteoglycan of
the glomerular BL (Groffen et al., 1998b). In view of evi-
dence that heparan sulfate proteoglycans are critical de-
terminants of renal permeability (Kanwar et al., 1991),
agrin has been suggested to be an essential part of the
glomerular filter (Raats et al., 2000). Likewise, agrin is
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prominent in the BLs of the cerebral microvasculature,
and its levels in this BL increase during the period that the
blood–brain barrier acquires its mature properties. This
pattern of expression has led to the speculation that agrin
contributes to the integrity of this barrier (Barber and Li-
eth, 1997). Despite these intriguing data, little is known
about roles of agrin at sites other than the neuromuscular
junction, or about how its expression and subcellular local-
ization are regulated in any tissue.
Clues to the mechanism of agrin’s action at the neuro-
muscular junction have come from analysis of its multiple
isoforms. Alternative splicing near the 3
 
9
 
 end of the agrin
gene generates isoforms that contain or lack short seg-
ments in the COOH-terminal third of the protein. Inclu-
sion of a four amino acid (aa) insert at a site called A in
chicks and Y in mammals is required for agrin to bind to
heparin. Inclusion of 8, 11, or 19 (8 
 
1 
 
11) aa segments at a
nearby site, called B in chicks and Z in mammals, is re-
quired for agrin to induce postsynaptic differentiation at
the neuromuscular junction (Ferns et al., 1992; Ruegg et
al., 1992; Gesemann et al., 1995, 1996; Campanelli et al.,
1996; O’Toole et al., 1996; Burgess et al., 1999). Here we
describe heterogeneity in the 5
 
9
 
 end of the agrin gene that
contributes to the diversity of agrin’s localization, tissue
distribution, and function. We show that mice express two
isoforms of agrin in which distinct NH
 
2
 
-terminal peptides
of 49 or 150 aa precede 
 
z
 
1,900 aa of common sequence.
We refer to the isoforms as short NH
 
2
 
-terminal (SN) and
long NH
 
2
 
-terminal (LN), respectively. The existence of
these distinct isoforms explains the previously noted lack
of homology between the NH
 
2
 
 termini of agrins isolated
from rats and chicks (Rupp et al., 1991; Tsim et al., 1992;
Denzer et al., 1995). SN- and LN-agrins are likely to be
transcribed from distinct promoters, and they are ex-
pressed in different patterns throughout development. SN-
agrin is largely confined to the nervous system, whereas
LN-agrin is broadly distributed in neural and nonneural
tissues. Moreover, analyses of native and recombinant
protein indicate that SN- and LN-agrin exhibit distinct
subcellular localizations, determined by their NH
 
2 
 
termini:
LN-agrin associates with BLs (and all BL-associated agrin
is LN-agrin), whereas SN-agrin remains attached to cell
surfaces. Finally we use mutant mice in which expression
of only LN-agrin is abolished to show that this isoform is
essential for synapse formation at the neuromuscular junc-
tion. Thus, analyses of gene expression, protein localiza-
tion, and mutant phenotype all support the idea LN-agrin
is a component of BLs and critical for signaling at the neu-
romuscular junction, whereas SN-agrin may play distinct
roles in neuron–neuron interactions.
 
Materials and Methods
 
Analysis of cDNA and Genomic Clones
 
To identify cDNAs encoding 5
 
9
 
 ends of agrin, we performed anchored
PCR from an embryonic day (E) 18 mouse library (CLONTECH Labora-
tories, Inc.). A primer in exon 1 of agrin (according to the numbering
scheme of Rupp et al., 1992) and a second primer in the vector were used
for amplification. Reaction products were separated on agarose gels, blot-
ted to filters, and hybridized with 
 
32
 
P-labeled agrin-specific oligonucle-
otides. A fragment identified in this way was sequenced, and found to en-
code SN-specific–translated and 5
 
9
 
-untranslated sequences. Its sequence is
available from EMBL/Genbank/DDBJ (accession number AF294811).
 
LN-agrin was identified by a search of public databases; an EST (acces-
sion number AA024084) was obtained and resequenced. Bacterial artifi-
cial chromosomes containing the 5
 
9
 
 end of the agrin gene were identified
by PCR screening of gridded clones from a commercial library (Genome
Systems). Two positive clones were mapped by restriction digestion and
Southern blotting. Sequencing to determine the intron–exon boundaries
was performed directly from the bacterial artificial chromosomes DNA
using 5 
 
m
 
g of DNA per reaction.
 
Expression of Recombinant Agrin
 
CHO cells were grown on glass coverslips coated with laminin (GIBCO
BRL; 20 
 
m
 
g/ml). The cells were transfected with cDNAs encoding either
full-length rat agrin (Campanelli et al., 1991) or with a construct express-
ing the first 83 aa of rat SN-agrin fused to a COOH-terminal FLAG tag.
This construct was generated by PCR and contained the same 5
 
9
 
 UTR and
the first 249 base pair (bp) of coding sequence as the full-length rat agrin.
At the 3
 
9
 
 end, an MfeI site was added and the PCR product was ligated
into an expression vector upstream of a FLAG tag. An LN-agrin expres-
sion construct was made in the same vector; it began with the first 15 aa of
the chick sequence, followed by mouse LN-agrin sequence.
After transfection, living cells were stained at 37
 
8
 
C for 30 min using ei-
ther a polyclonal anti-agrin antibody generated against the COOH-termi-
nal 50 kD of human agrin (a gift of David Glass, Regeneron Pharmaceuti-
cals, Tarrytown, NY), or with anti-FLAG monoclonal antibody M2
(Sigma-Aldrich). The cells were then washed briefly, fixed in 4%
paraformaldehyde, and incubated with fluorescein-conjugated anti–
mouse or Alexa 488–conjugated anti–rabbit secondary antibodies.
 
Transcript Analysis
 
RNA was isolated for reverse transcriptase (RT)-PCR by homogenization
in guanidinium isothiocyanate and phenol extraction. For reverse tran-
scription, 10 
 
m
 
g of total RNA was incubated with Avian Myelosis Virus
RT and a mixture of random hexamers and oligo-dT. For PCR, aliquots of
the resulting cDNA were amplified 40 rounds using primers indicated in
the figures. For Northern blotting, mRNA was isolated by passage over an
oligo-dT cellulose column. Denaturing gels were run and blotted onto ny-
lon membrane. In most cases, 5 
 
m
 
g of poly A
 
1
 
 mRNA was loaded per
lane. Probes were generated using 
 
32
 
P incorporation by random priming
of PCR products specific for each transcript. Hybridization was carried
out at 50
 
8
 
C in 50% formamide buffer, and the final wash was 0.2
 
3
 
 SSC,
0.1% SDS at 65
 
8
 
C. Equivalent loading of lanes was assessed by stripping
blots and reprobing them with elongation factor 1
 
a 
 
(EF1
 
a
 
).
 
Gene Trapping
 
A mutation in the agrin locus was generated by the insertion of a 
 
b
 
-geo
gene (neomycin phosphotransferase fused to 
 
Escherichia coli
 
 
 
b
 
-galactosi-
dase [lacZ]) between the LN and SN exons. This insertion was identified
from an insertional mutagenesis screen in embryonic stem (ES) cells that
had been designed to identify mutations in genes encoding secreted and
transmembrane proteins (Skarnes et al., 1995). Individual clones from this
screen were analyzed by 5
 
9
 
 RACE (rapid amplification of cDNA ends) to
identify the intercepted transcripts (Townley et al., 1997). ES cells were
injected into mouse blastocysts to generate germ line chimeras.
 
Histology
 
For lacZ staining, tissues were fixed in 4% paraformaldehyde, with or
without 0.25% glutaraldehyde, at room temperature. Tissue was then
equilibrated with 15% and 30% sucrose in PBS, frozen, and sectioned in a
cryostat at 10–20 
 
m
 
m. Slides were stained at 30
 
8
 
C for 6–18 h as described
by Sanes et al. (1986) and then mounted in 80% glycerol for viewing.
Tissue sections or whole muscles were prepared for immunohistochem-
istry as described in Burgess et al. (1999). Agrin staining was done using a
rabbit polyclonal antibody against the COOH-terminal 50 kD of human
agrin. Nerves were visualized with anti-NF200 (Sigma and Sternberger
Monoclonals) and anti-SV2 (Buckley and Kelly, 1985) or anti-synapto-
physin (Zymed Laboratories). AChRs were stained with rhodamine
 
a
 
-bungarotoxin (Molecular Probes).
For in situ hybridization, tissue was fixed overnight in 4% paraformal-
dehyde, equilibrated with 15% and 30% sucrose, frozen and sectioned as
above. The tissue was allowed to air dry for up to 2 h and then hybridized
immediately. Hybridization was done using a solution of 
 
z
 
250 ng/ml
digoxygenin-labeled riboprobes in a 50% formamide buffer at 65
 
8
 
C over- 
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night and washed and developed according to Schaeren-Wiemers and
Gerfin-Moser (1993). The SN probe included the entire unique 5
 
9
 
 un-
translated (466 nucleotides) and unique coding sequence to the HinfI site.
 
Clustering Activity Assay
 
Brains and spinal cords from E18 mice were homogenized and used to in-
duce AChR clustering on myotubes as described in Sanes et al. (1984). In
brief, tissue was dissected from the animals, homogenized in ground glass
homogenizers at 25% wt/vol in DME with 10% horse serum. The homog-
enate was then spun at 4
 
8
 
C in a microfuge for several hours and the super-
natant was sterilized by passage through a 0.2-
 
m
 
m syringe filter. The su-
pernatant was diluted and applied to myotubes that had been cultured
from neonatal mice as described by Gautam et al. (1996). After 18 h of
treatment, the myotubes were fixed in 2% paraformaldehyde, rinsed in
PBS, and stained with rhodamine 
 
a
 
-bungarotoxin for 2 h. The coverslips
were then mounted and the number of AChR clusters was counted.
 
Results
 
Isolation of Chicklike and Ratlike Agrin Isoforms
 
cDNAs encoding agrin have been isolated from rat, Tor-
pedo, chicken, human, and mouse (Rupp et al., 1991, 1992,
Ruegg et al., 1992; Smith et al., 1992; Denzer et al., 1995;
Groffen et al., 1998a). The deduced primary sequence is
highly conserved among all of these species with one note-
able exception: the NH
 
2
 
-terminal 50 residues of rat agrin
(Rupp et al., 1991) are unrelated to sequences in other
agrins or to any other sequences in public databases. In
contrast, NH
 
2 
 
termini of reported human and mouse
agrins are homologous to the sequence initially isolated
from chick (Torpedo sequence did not extend to the NH
 
2
 
terminus). Although this difference might reflect authentic
interspecific differences, we considered an alternative pos-
sibility, that multiple agrin mRNAs with different 5
 
9
 
 ends
exist in a single species (Fig. 1 A). Because our previous
studies of agrin function have been performed in mice
(Gautam et al., 1996, 1999; Burgess et al., 1999), we began
the present study by seeking an isoform of mouse agrin
with a ratlike NH
 
2 
 
terminus.
A cDNA encoding the NH
 
2 
 
terminus of agrin was
cloned by anchored PCR from an embryonic mouse
cDNA library (see Materials and Methods). This 700-bp
PCR product contained 466 bp of 5
 
9
 
-untranslated se-
quence (5
 
9
 
 UTR) followed by 148 bp of coding sequence
homologous to rat but not chick agrin, and then 73 bp of
sequence homologous to both chick and rat agrin (Fig. 1
B). The 5
 
9
 
 UTR contained stop codons upstream of the
proposed start ATG, confirming the NH
 
2 
 
terminus of the
agrin open reading frame. This mouse NH
 
2 
 
terminus, like
the rat sequence, lacks a canonical signal peptide. If the
NH
 
2 
 
terminus were to function as a leader sequence, its
most likely cleavage site based on the parameters of von
Heijne (1986), is predicted to after residue 52, 3 aa into the
common sequence.
We also confirmed the existence of murine cDNAs that
encode a chicklike NH
 
2 
 
terminus. In a search of public da-
tabases, several ESTs corresponding to the NH
 
2 
 
terminus
of agrin were identified and one was obtained and se-
quenced. The 5
 
9
 
 end of this cDNA encoded a peptide that
was highly homologous to aa 16–211 of chick agrin but was
dissimilar to rat agrin before aa 150 (Fig. 1 B). In chick, al-
ternative splicing leads to the inclusion or exclusion of a 7
aa stretch at approximately aa 150 (Denzer et al., 1995;
Tsen et al., 1995). All of the ESTs we identified lacked this
7 aa stretch, and attempts to identify it by PCR and RT-
PCR gave negative results (data not shown). Therefore,
this exon may not be present in mice.
These results, and others presented below, demonstrate
that the agrin gene encodes two classes of patterns, in
which unique sequences of 49 or 150 aa precede 
 
z
 
1,900 aa
of common sequences. 
 
Distinct Subcellular Localizations of LN- and SN-Agrin
 
Denzer et al. (1995, 1997) reported that recombinant chick
agrin (LN-type) is secreted from transfected COS cells
and binds to laminin in the extracellular matrix. In con-
trast, Campanelli et al. (1991) found that recombinant rat
agrin (SN-type) is externalized by transfected CHO cells,
but remains associated with the cell surface. Although
these studies used different methods and analyzed agrin
from different species, their results suggested that the lo-
calization of agrin is affected by its NH
 
2 
 
terminus. To test
Figure 1. Distinct NH2 ter-
mini of agrin. (A) Schematic
of agrin protein structure,
showing its major domains
(laminin G domains, EGF
repeats, and follistatin [F] re-
peats), sites of alternative
splicing (X, Y, Z) and alter-
nate NH2-terminal exten-
sions (SN and LN). (B) The
two alternative NH2 termini
of mouse agrin, aligned with
prototype LN and SN se-
quences from chick and rat,
respectively. Dots indicate
identity. The boxed hep-
tapeptide in the chick se-
quence represents an alter-
natively spliced exon; a
homologous segment has not
yet been identified in murine
LN-agrin. 
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this idea, we generated expression vectors in which the
NH
 
2 
 
termini of mouse LN- and SN-agrins were fused to
the FLAG epitope tag. The SN–FLAG vector encoded the
49 aa of SN-specific sequence plus 34 aa of common se-
quences, whereas the LN–FLAG vector encoded 150 aa of
LN-specific sequences plus the same 34 aa of common se-
quence. These vectors were transfected into CHO cells,
which had been plated on dishes coated with laminin. Two
days later, the cultures were stained either live or after fix-
ation and permeabilization.
As shown in Fig. 2 A, the SN–FLAG fusion protein was
efficiently externalized, and remained associated with the
surface of transfected CHO cells. Staining extended to the
tips of cellular processes. We did not observe any staining
of presumably untransfected cells in the vicinity of SN–
FLAG-rich (transfected) cells, suggesting that the fusion
protein remained associated with the membrane after ex-
ternalization, rather than being secreted and then re-
trieved from the medium. In all of these respects, the dis-
position of SN–FLAG was indistinguishable from that of
full-length rat agrin (Fig. 2, C and D; and Campanelli et
al., 1991). In contrast, cells transfected with the LN–
FLAG vector were intensely stained after permeabiliza-
tion, but not detectably stained when incubated with anti-
FLAG before fixation (Fig. 2, E and F).
 
Selective Expression of SN-Agrin in Nervous System
 
We used Northern blotting to compare expression pat-
terns of SN- and LN-agrin mRNAs. Blots were probed se-
quentially with four probes: one comprising LN-specific
sequences (Fig. 3 A), a second comprising SN-specific se-
Figure 2. The NH2 terminus of SN-agrin mediates its associa-
tion with cells. CHO cells were transfected with vectors encoding
the NH2 terminus of SN-agrin fused to FLAG (A and B), full-
length SN-agrin (C and D), or the NH2 terminus of LN-agrin
fused to FLAG (E and F). Cells were stained with anti-FLAG
(A, B, E, and F) or anti-agrin (C and D), either live to detect cell
surface proteins (A, C, and E) or after fixation and permeabiliza-
tion (B, D, and F). SN-agrin reached the cell surface, but no
staining of live cells was detctable with the LN–FLAG construct.
Staining of fixed and permeabilized cells indicated expression
levels were similar for each construct. Bar, 20 mm.
Figure 3. Tissue distribution of LN- and SN-agrin. (A–D)
Northern analysis. Blots were hybridized sequentially with
probes specific for LN-agrin (A), SN-agrin (B), all agrin isoforms
(C), and the ubiquitously expressed RNA, EF1a (D). In adults,
LN-agrin RNA is broadly distributed whereas SN-agrin is selec-
tively expressed in brain. Both forms are present at E13 and E17
(RNA was from whole embryos). The sum of SN- and LN-agrins
appear to account for the common signal. (E) Analysis of E18
CNS and muscle RNA by RT-PCR indicated that LN is present
in both tissues, whereas SN was below the level of detection in
muscle. NT, PCR performed with a mixture of LN and SN prim-
ers but no template. The PCR strategy and predicted sizes of
products are shown in the sketch. (F) Analysis of cortical glial
cultures by RT-PCR indicates that LN is expressed by glia,
whereas SN is not. The strategy is the same as that in E. 
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quences (Fig. 3 B), a third comprising common sequences
(Fig. 3 C), and a fourth that recognized products of the
ubiquitously expressed gene, EF1
 
a
 
 (Fig. 3 D). SN-specific,
LN-specific, and common probes all hybridized to a band
of 8.2 kb. In adults, LN-agrin RNA was present in all tis-
sues tested, whereas SN-agrin was selectively expressed in
brain. (A long exposure of the SN Northern blot revealed
low levels of expression in lung; data not shown.) Both
LN- and SN-agrin were expressed in embryos, at levels
that declined with age. Likewise, SN- and LN-agrin RNAs
were more abundant in P2 brain than in adult brain, and
LN-agrin RNA was more abundant in P2 muscle than in
adult muscle. In all tissues tested, RNAs detected with the
common probes appeared to represent the sum of LN- and
SN-specific signals, supporting the idea that LN and SN
transcripts together account for all agrin transcripts.
To date, agrin has been most intensively studied in the
central nervous system and in muscle. To further examine
the expression of SN and LN isoforms in these two tissues,
we used RT-PCR. As shown in Fig. 3 E, a reverse primer
in the second common exon was paired with either an SN-
or a LN-specific primer. SN-agrin RNA was readily de-
tected in E18 central nervous system (brain and spinal
cord), but was barely detectable in E18 muscle. In con-
trast, LN-agrin RNA was detectable in both tissues. These
results confirm that both LN- and SN-unique sequences
are continuous with common sequence, and support the
conclusion from Northern blotting that SN-agrin is selec-
tively expressed in nervous tissue.
 
Genomic Organization of the LN and SN Exons
 
Knowing that LN- and SN-agrin RNAs are differentially
expressed, we asked how LN-specific, SN-specific, and
common sequences are arranged in the agrin gene. To this
 
end, we isolated a 
 
.
 
100-kb genomic clone that carried
both SN- and LN-specific coding sequences. The clone was
restriction mapped and partially sequenced to determine
intron–exon boundaries. As shown in Fig. 4, LN-specific
sequences are encoded by at least three exons, all of which
lie within a 5-kb stretch. These exons are 8-kb upstream of
a single exon that encodes the entire SN-specific coding
sequence as well as the SN-specific 5
 
9
 
 UTR. The SN exon,
in turn, is separated from the first two common exons by
introns of 0.4 and 4 kb.
 
Isolation of a LN-specific Gene Trap Insertion
 
Skarnes et al. (1995) performed a “gene-trap” screen in
which the mutagenic cassette contained a splice acceptor
site followed by a 
 
b
 
-geo fusion protein. Inclusion of a
transmembrane domain in the cassette led to selection for
proteins with signal sequences. 5
 
9
 
 RACE was then used to
identify the transcripts that had been intercepted by the
gene trap insertion (Townley et al., 1997). One RACE-
derived sequence (Ex192) corresponded to the LN-spe-
cific NH
 
2 
 
terminus of agrin, and ended precisely at the 3
 
9
 
end of the last LN exon (compare Figs. 4 B and 5 A). This
sequence suggested that the vector had integrated into the
intron that separated the LN exons from the SN exon.
Southern blot analysis of genomic DNA confirmed this lo-
cation (not shown). We generated chimeric mice from
these ES cells by blastocyst injection and then bred the
chimeras to generate heterozygous and eventually ho-
mozygous mutants. Heterozygotes were phenotypically
normal, and homozygotes exhibited defects described
below.
Expression of agrin isoforms was examined in the mu-
tant animals by Northern blotting, using LN- and SN-spe-
cific probes. The LN-specific probe recognized a transcript
Figure 4. Location of SN, LN, and common exons in the mouse agrin gene. (A) Map of the 59 end of the agrin gene, as determined by
restriction digestion, PCR, and Southern blotting. LN-specific sequences are encoded by at least three exons that lie 8-kb upstream of a
single exon that encodes SN-specific sequences. The SN exon is separated by introns of 0.4 and 4 kb from first and second common ex-
ons. The second common exon corresponds to the first exon mapped by Rupp et al. (1992). (B) Predicted pattern of splicing to generate
LN- and SN-agrin transcripts. The intron–exon boundaries all contain concensus splice donor (gt) and acceptor (ag) sequences and pre-
serve the predicted agrin reading frame. 
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of 8.2 kb in wild-type mice and a transcript of 6.0 kb in
agrin
 
LN/LN
 
 mice (Fig. 5 B). The decrease in size reflects the
replacement of 
 
z
 
7 kb of common agrin sequence by 
 
z
 
5
kb of 
 
b
 
-geo sequence. As expected, both 6.0- and 8.2-kb
LN-reactive RNAs were present in agrin
 
LN/
 
1
 
 heterozy-
gotes. In contrast, the SN-specific probe recognized RNAs
of identical size and abundance in mice of all three geno-
types (Fig. 5 C). Likewise, levels of SN-agrin were simi-
larly low in nonneuronal tissues of both agrin
 
LN/LN
 
 and
control animals (not shown), indicating that SN-agrin is
not upregulated in the absence of LN.
 
The complete absence of 8.2-kb RNA from the mutant
suggested that the insert intercepted most if not all LN
transcripts. To assess the completeness of the disruption,
we used the more sensitive method of RT-PCR, using
primers diagrammed in Fig. 5 D. LN transcripts were in-
tercepted by the 
 
b
 
-geo construct and wild type LN tran-
scripts were undetectable in homozygous mutant (Fig. 5, E
and F). There was no evidence for splicing from the insert
to the SN exons, consistent with the genomic analysis indi-
cating that the insertion is upstream of the SN exon. To-
gether, Southern, Northern, and RT-PCR analyses indi-
cate that the gene trap insert has generated an effective
null allele of LN-agrin, with no detectable effect on ex-
pression of SN-agrin.
 
Distinct Patterns of LN- and SN-Agrin Expression in 
Central Nervous System
 
In the agrin
 
LN 
 
allele, genomic regulatory elements that
normally direct expression of LN-agrin would be expected
to direct expression of a LN–
 
b
 
-geo fusion protein, which is
detectable with the histochemical stain for lacZ. We there-
fore used lacZ histochemistry to assess the cellular distri-
bution of LN-agrin in the central nervous system of phe-
notypically normal agrin
 
LN/
 
1
 
 
 
heterozygotes at E14 and
E18. Weak signals were present in numerous areas, includ-
ing cerebellum, cortex, and hippocampus, but four sites of
expression were especially prominent at both ages. First,
small blood vessels were intensely stained throughout the
nervous system (Fig. 6, A and B). Second, neural progeni-
tors were stained in the ventricular zones of the cerebral
cortex (Fig. 6 B), hippocampus (Fig. 6 D), and spinal cord
(Fig. 6 E). Third, sensory neurons were lacZ positive in
dorsal root ganglia (Fig. 6 E) and in the trigeminal gan-
glion (not shown). Fourth, motoneurons were intensely
stained, indicating that these cells express high levels of
LN-agrin. Selective staining of motoneurons was apparent
both in the spinal cord (Fig. 6 E) and in the hindbrain (Fig.
6 H). Staining was intense at both E14 and E18, and ex-
pression persisted into adulthood (Fig. 6 I). Selective ex-
pression of LN-agrin by motoneurons is noteworthy in
view of functional studies reported below.
In parallel we used in situ hybridization to confirm the
localization of LN-agrin (not shown) and to map expres-
sion of SN-agrin (Fig. 6, C and F). The pattern of SN-agrin
expression was markedly different from that of LN-agrin.
In forebrain, for example, levels of SN-agrin were highest
in postmitotic neurons of the cortical plate, moderate in
migrating neuroblasts of the intermediate zone, and lowest
in progenitors of the ventricular zone. This pattern was the
opposite of that seen for LN-agrin, which was expressed at
highest levels in the ventricular zone and at lowest levels
in the cortical plate (Fig. 6, B and C). In spinal cord, SN-
agrin was broadly distributed, in contrast to the motoneu-
ron-selective expression of LN-agrin (Fig. 6, E and F). SN-
agrin RNA was also abundant in midbrain, hindbrain,
retina, olfactory epithelium, trigeminal ganglion, and sym-
pathetic ganglia (not shown).
The broad distribution of SN-agrin RNA in the CNS
raised the possibility that this isoform was expressed by
glial cells in addition to neurons. To test this possibility, we
used isoform-specific primers to amplify agrin mRNAs
Figure 5. Characterization of a gene trap insertion that selec-
tively intercepts LN-agrin transcripts. (A) Partial sequence of the
transcript intercepted by the agrinLN gene trap insertion was de-
termined by 59 RACE. The sequence matches LN-agrin and ter-
minates at the end of the LN-specific exon. (B and C) Northern
analysis of poly A1 mRNA from the CNS of E18 agrinLN/LN,
agrinLN/1, and agrin1/1 littermates, hybridized with LN- (B) and
SN-specific (C) probes. The wild-type LN transcript is shifted
from 8.2 to 6.0 kb by the b-geo insertion, whereas the size and
abundance of the SN transcript are unaffected. Blots were stan-
dardized with EF1a. (D–F) RT-PCR analysis of RNA from CNS
of mutants and controls, using strategy shown in D. Amplifica-
tion from LN to b-geo yielded a band in mutants but not wild-
type littermates, whereas primers in SN and b-geo gave no ampli-
fication product in either genotype (E). The wild-type transcript
for SN-agrin was still present in mutant CNS, but the LN tran-
script is below the level of detection by RT-PCR (F).Burgess et al. NH2-terminal Agrin Variants 47
Figure 6. Expression of LN- and SN-agrin. The b-geo insertion allowed LN-agrin expression to be analyzed by lacZ staining in het-
erozygotes (A, B, D, E, and G–L), whereas SN-agrin RNA was detected by in situ hybridization (C, F, M, and N). (A and B) In the
brains of E14 mice, LN-agrin is expressed in cerebral blood vessels and in the ventricular (vz) and intermediate zone (iz) of the cortex,
but not in the cortical plate (cp; B). (C) SN-agrin is expressed in a pattern that is complementary to the LN pattern, being most abun-
dant in the postmitotic cells of the cortical plate. (D) In E18 embryos, LN-agrin continues to have very restricted expression in the hip-
pocampus, being present only near the ventricles and in blood vessels. (E) In the spinal cord, LN-agrin is strongly expressed by moto-
neurons and sensory neurons of the DRG (arrows). (F) SN-agrin is widely distributed in many neuronal cells types in both the DRG
and the spinal cord, although motoneurons are not more intensely positive than other cell types (white arrows). (H) LN-agrin is also ex-
pressed by cranial nerve motor nuclei in the hindbrain (E18 horizontal section; IV, forth ventricle; arrowheads, oculomotor nuclei). (I)
Motoneuron expression of LN-agrin persists into adulthood. (G and J–N) Nonneuronal cells that abut basal laminae express LN-agrin
but not SN-agrin. Epidermal cells in E18 skin (G), kidney glomeruli and tubules (J), and pulmonary epithelium (K) are all positive for
LN-agrin. No lacZ activity was present in littermate controls in any tissue (E18 kidney shown, L). Consistent with northern blotting,
SN-agrin is not expressed at levels detectable by in situ hybridization in nonneuronal tissues such as kidney (M) or lung (N).The Journal of Cell Biology, Volume 151, 2000 48
from isolated, cultured cortical glia. LN-agrin was ex-
pressed by the glia (which include the astrocytes that con-
tribute to the microvascular BL), but SN was not (Fig. 3
F). Thus SN-agrin may be selectively expressed not only in
the nervous system, but by neurons.
BL-associated Agrin Is the LN Isoform
Selective expression of SN-agrin in the nervous system
(Fig. 3) suggested that BL-associated agrin in nonneural
tissue is predominantly if not entirely the LN isoform. We
tested this idea in two ways. First, we used lacZ histochem-
istry and in situ hybridization to map SN- and LN-agrin
expression in cells that abut BLs. In skin, epidermal cells
abutting the BL that separates the dermis from the epider-
mis were positive for LN-agrin based on lacZ staining (Fig.
6 G). In the developing kidney, glomeruli and a subset of
tubules were positive for LN-agrin (Fig. 6 J). In the lung,
LN-agrin was expressed primarily by pulmonary epithelial
cells (Fig. 6 K). In contrast, SN-agrin RNA was undetect-
able in all nonneural tissues tested, including lung, kidney,
and skin, in which LN is abundant (Fig. 6, M and N; and
data not shown).
Second, we used immunohistochemistry to map the dis-
tribution of agrin protein in agrinLN/LN mutants. As re-
ported previously and discussed above, agrin is present in
numerous BLs of wild-type mice, including microvascular
BLs in brain (Fig. 7 A), glomerular BL in kidney (Fig. 7
C), and meningeal sheaths (Fig. 7 E), as well as skin, ret-
ina, and lung (not shown). No agrin immunoreactivity was
detectable in any of these sites in agrinLN/LN embryos and
neonates (Fig. 7, B, D, and F; and data not shown). The
lack of staining did not reflect disappearance of the BL, as
shown by staining with antibodies to broadly distributed
BL components such as laminin (Fig. 7, G and H; and data
not shown). Together, these results show that all detect-
able BL-associated agrin is of the LN isoform, and that
agrin is not essential for formation of BLs.
Impaired Synapse Formation in the Absence
of LN-Agrin
AgrinLN/LN mice died at birth and exhibit no spontaneous
movements, including respiratory movements. In this re-
spect, the LN-specific mutants resembled mice lacking all
forms of agrin or the bioactive Z-agrin isoform, both of
which fail to form neuromuscular junctions (Gautam et al.,
1996; Burgess et al., 1999; Burgess, R.W., and J.R. Sanes,
manuscript in preparation).
Histological analysis demonstrated that neuromuscular
structure was drastically disrupted in agrinLN/LN muscles.
In wild-type muscles, motor axons form a central nerve
trunk; individual axons leave the trunk, branch, and termi-
nate on myotubes (Fig. 8 A). Each nerve terminal orga-
nizes a postsynaptic apparatus, rich in AChRs (Fig. 8 A9)
and acetylcholinesterase (Fig. 8 C). In agrinLN/LN muscles,
intramuscular nerve trunks form, but motor axons sprout
abnormally and form few nerve terminals (Fig. 8 B). Few
AChR clusters and acetylcholinesterase deposits form
(Fig. 8, B9 and D). Those AChR clusters that do form are
smaller and dimmer than those in control muscles (insets
in Fig. 8, A9 and B9 ), and fewer than half of them are ap-
posed to nerve terminals. In all these respects, the synaptic
defects observed in agrinLN/LN muscle are identical to
those previously documented in detail for other agrin mu-
tants (Gautam et al., 1996, 1999; Burgess et al., 1999).
Figure 7. LN-agrin accounts for all
agrin in BLs. Immunohistochemistry
with an anti-agrin antibody shows that
agrin is present in BLs of cerebral mi-
crovasulature (A), renal glomeruli (C),
and pia and sheath of the optic nerve
(E) at E18. No immunoreactivity is
detectable at any of these sites in
agrinLN/LN mice (B, D, and F). Basal
laminae remain intact as indicated by
anti-laminin staining in wild-type (G)
and agrinLN/LN mutant (H) kidney. Bar:
(A, B, E, and F) 250 mm; (C and D)
50 mm; and (G and H) 125 mm.Burgess et al. NH2-terminal Agrin Variants 49
We also examined the distribution of agrin in muscles of
control and agrinLN/LN neonates. In wild-type adult mus-
cles, agrin is highly concentrated in the BL of the synaptic
cleft (McMahan, 1990). In embryos, however, agrin is
present throughout the myotube BL (Hoch et al., 1993); a
concentration of agrin immunoreactivity at synaptic sites
becomes detectable around the time of birth (Fig. 8, E and
E9). In agrinLN/LN mutants, no agrin was detectable in myo-
tube BL, consistent with our conclusion that all BL-associ-
ated agrin is of the LN form (Fig. 8 F). Importantly, agrin
was also undetectable at sites of nerve–myotube contact in
mutant muscles (Fig. 8, F and F9), indicating that most if
not all synaptic agrin, presumably including motoneuron-
derived agrin, is also of the LN form.
SN-Agrin Has AChR Clustering Activity
The similar neuromuscular defects of agrin LN/LN and agrin
null mutants raised the possibility that SN-agrin is incapa-
ble of inducing postsynaptic differentiation. We tested this
idea in two ways. First, we assessed the alternative splicing
pattern of SN-agrin transcripts. Previous studies have
shown that inclusion of either exon 32, 33, or both at a 39
site called “Z” markedly enhances AChR clustering activ-
ity in vitro and is necessary for synaptic differentiation in
vivo (see Introduction). In addition, inclusion of exon 28
at a nearby site called “Y” is required for agrin to bind to
heparin, although the physiological significance of this
Figure 8. Neuromuscular junctions fail to form in agrinLN/LN
muscle. (A and B) Diaphragms from E18 mice were stained with
antibodies against neurofilaments and synaptophysin to visualize
axons (A and B) and with a-bungarotoxin to visualize AChRs
(A9 and B9). In wild-type mice (A and A9), the synapses form a
narrow endplate band in the center of the muscle. Plaques of
AChRs are clear and bright (A9, inset). In agrinLN/LN muscle (B
and B9), neurites fail to stop at synaptic sites and little postsynap-
tic specialization is seen. Small, dim clusters of AChRs are
present (B9, inset), but they are usually not apposed to nerves. (C
and D) Acetylcholinesterase accumulates in the end plate band
of E18 control muscles (C) but not agrinLN/LN muscles (D). At
E18, agrin is present in the extra-synaptic basal lamina of control
myotubes, as shown in cross-sections of intercostal muscle (E).
All muscle agrin staining is eliminated in agrinLN/LN mice (F).
Motor nerve terminal, identified by SV2 staining (E9 and F9) are
associated with agrin accumulations in wild-type (E and E9) but
not mutant (F and F9) muscles, suggesting that most synaptic
agrin is of the LN form. Bar: (A and B) 50 mm; (C and D) 100
mm; (A9 and B9, insets) 20 mm; and (E and F) 20 mm.
Figure 9. SN-agrin is bioactive. (A and B) RT-PCR of RNA
from brains of E18 agrinLN/LN mice and littermate controls, using
primers that span the Y (A) and Z (B) exons. Both Y1 and Y2
transcipts are present in both genotypes with Y1 transcripts pre-
dominant. Multiple Z1 transcripts (with 24-, 33-, and 57-bp in-
serts) as well as Z2 transcripts are also present in similar propor-
tions in wild-type and mutant brains, indicating that SN-agrin is
subject to alternative splicing at sites that determine its bioactiv-
ity. (C) Brain extracts from agrinLN/LN mice were applied to cul-
tured primary myotubes and clustering activity was assayed. The
activity of control and mutant brain extracts was the same, sug-
gesting that SN-agrin is capable of inducing AChR clusters in
vitro. Virtually all clustering activity is due to agrin since extracts
from a agrin null mutant induce few clusters (Burgess, R.W., and
J.R. Sanes, manuscript in preparation; redrawn as light gray bars).The Journal of Cell Biology, Volume 151, 2000 50
binding is unknown (Gesemann et al., 1996; Burgess et al.,
1999). We therefore used RT-PCR to determine the Y and
Z splice forms of agrin present in agrin LN/LN mice. As LN
transcripts are undetectable in these animals (Fig. 5, B and
F), all residual agrin in these mutants is likely to be SN-
agrin. The remaining transcripts included those that were
Y1, Y2, Z1, and Z2. Moreover, the proportions of the var-
ious forms did not differ appreciably between mutants and
littermate controls (Fig. 9, A and B). Thus SN- as well as
LN-agrin bears the Z exons required for synaptic organiz-
ing activity.
Second, we used myotube cultures to test whether LN-
agrin accounts for all of the bioactive agrin in the central
nervous system. Cultures were incubated for 18 h with ex-
tracts from wild-type brain and spinal cord and then
stained with rhodamine–a-bungarotoxin to label AChRs.
Extracts from wild-type brain induced a dose-dependent
increase in the number of AChR clusters. Extracts from
agrin null mutants were nearly inactive in this assay, indi-
cating most of the AChR clustering activity in soluble ex-
tracts of the central nervous system is attributable to agrin
(Burgess, R.W., and J.R. Sanes, manuscript in prepara-
tion; redrawn as light gray bars in Fig. 9 C). Extracts from
agrinLN/LN tissue were nearly as effective in inducing
AChR clusters as extracts from littermate controls (Fig. 9
C). Together, these results provide evidence that SN-agrin
has AChR-clustering activity in vitro. The result that lev-
els of this bioactivity are similar in control and agrinLN/LN
brains presumably reflects the fact that LN/Z1 agrin has a
limited distribution: there is more SN- than LN-agrin in
neurons, most of the Z1 agrin in brain is likely to be SN/
Z1, and most of the LN agrin is likely to be LN/Z2. We
therefore believe that the requirement for LN-agrin in
postsynaptic differentiation reflects the appropriate cellu-
lar (motoneurons) and subcellular (BL) localizations of
this isoform.
Discussion
Molecular cloning of agrin from rat and chick revealed
that the protein sequences are highly conserved between
species with the exception of their NH2 termini, which dis-
play no similarity at all. We have now shown that this di-
vergence reflects the existence of two agrin isoforms in
which distinct NH2 termini of 49 aa (ratlike or SN) or 150
aa (chicklike or LN) are fused to z1,900 aa of common se-
quence. The two isoforms are expressed in different pat-
terns, with LN-agrin being broadly expressed and SN-
agrin being selectively expressed in the nervous system.
We believe these patterns are regulated transcriptionally
by elements near the 59 end of the gene. In addition, SN
and LN-agrin are localized to different compartments,
with LN being matrix associated and SN being attached to
plasma membranes. These differences are determined by
unique SN and LN NH2-terminal sequences. Interestingly,
inclusion of alternatively spliced segments in the COOH-
terminal quarter of agrin, which affect the bioactivity and
binding properties of the protein, are regulated indepen-
dently of the choice between SN and LN isoforms. We
propose that transcriptional regulation, alternative use of
NH2 termini and alternative splicing of COOH termini act
together to generate proteins with appropriate activities at
appropriate sites.
Gene Expression
LN-agrin is broadly expressed in neural and nonneural tis-
sues alike, whereas SN-agrin is selectively expressed in the
nervous system. Within the nervous system, LN- and SN-
agrins are also expressed in different patterns: SN is ex-
pressed by many postmitotic neurons whereas LN is ex-
pressed by neuroblasts, glia, cells of the microvasculature,
and restricted neuronal subpopulations, most notably mo-
toneurons.
The distinct distributions of SN- and LN-agrin RNAs
could result from any or all of three mechanisms: (a) tis-
sue-specific alternative splicing; (b) alternative promoter
usage; or (c) tissue-specific differences in mRNA stability.
We have no data that bear directly on the third possibility,
but view it as unlikely and note that it would likely to act
in conjunction with one of the other two. In contrast, we
have two reasons for believing that expression patterns re-
flect transcriptional regulation rather than regulated splic-
ing of a common transcript. The essential point is that al-
ternative splicing of a single transcript would require the
existence of a common upstream exon encoding untrans-
lated sequences, which would be spliced to either the LN
or the SN exons. However, the size of the SN-agrin
mRNA seen on Northern blots is accounted for by the size
of the SN exon plus known common translated and un-
translated sequences (Rupp et al., 1992). Therefore, any
common upstream exon would have to be quite small. Sec-
ond, and more compelling, the gene trap insertion in the
agrinLN allele would be expected to intercept all tran-
scripts initiated from the hypothetical upstream exon,
whether or not they also included LN exons. In fact, how-
ever, the trap intercepts LN transcripts virtually com-
pletely, yet has no detectable effect on the level of SN
transcripts. This result suggests that the insertion down-
stream of the LN exons and upstream of the SN exon
which is between the LN- and SN-agrin transcriptional
start sites. This arrangement, in turn, implies that LN- and
SN-agrin RNAs are transcribed from different promoters,
each associated with tissue-specific regulatory elements. A
testable prediction of our model is that an SN-agrin pro-
moter and neuron-specific enhancer lie in the ,4-kb inter-
val between the agrinLN insert and the SN-specific exon.
Protein Localization
Three lines of evidence indicate that LN-agrin is associ-
ated with BLs. First, recombinant full-length chick (LN)
agrin binds to BL components, including laminin (Denzer
et al., 1995, 1997). Second, nonneural tissues, in which
agrin is known to be associated with BLs, express LN-
agrin but not SN-agrin (Figs. 3 and 6). Third, no agrin is
detectable in BLs of agrinLN/LN mice, which express SN-
agrin but not LN-agrin (Fig. 7). In contrast, SN-agrin ap-
pears to be associated with cell surfaces. Recombinant,
full-length rat (SN) agrin remains attached to cell mem-
branes when synthesized and secreted by transfected cells
(Campanelli et al., 1991; and Fig. 2). Furthermore, agrin is
associated with axonal and synaptic membranes of neu-
rons, which express SN-agrin (Mann and Kroger, 1996;Burgess et al. NH2-terminal Agrin Variants 51
Halfter et al., 1997; Koulen et al., 1999). Interestingly, mo-
toneurons, which secrete agrin into BLs, are among the
few neuronal types that express LN- as well as SN-agrin.
The different subcellular localizations of LN- and SN-
agrin are attributable to their unique NH2-terminal se-
quences. Denzer et al. (1997) generated a fusion protein
consisting of the chick NH2 terminus including LN-specific
residues fused to an immunoglobulin tag. This protein
bound to a BL extract (Matrigel) and to purified laminin.
Conversely, a chick agrin protein lacking the NH2-termi-
nal sequences was unable to bind Matrigel or laminin. In a
conceptually similar experiment, we generated a fusion
protein in which the NH2 terminus of mouse SN-agrin is
fused to a FLAG epitope tag, and showed that this fusion
is externalized but remains associated with the surfaces of
cells that express it (Fig. 2). Thus, unique SN and LN se-
quences can endow heterologous proteins with the ability
to associate with cell membranes and BLs, respectively.
For LN-agrin, a direct binding of the LN sequences to do-
main I/II of the laminin g1 chain has been demonstrated
(Kammerer et al., 1999). For SN-agrin, the mode of mem-
brane association remains to be determined. It is notewor-
thy that the unique SN sequences contain neither a ca-
nonical signal peptide nor a predicted transmembrane
domain. It will be interesting to learn how SN sequences
are externalized and how they associate with the mem-
brane.
Association of Y and Z Exons with LN and SN
Previous studies of agrin isoforms have focussed on its
COOH-terminal variants. As noted in the Introduction,
inclusion of Z exons endows agrin with the ability to orga-
nize postsynaptic differentiation and inclusion of Y exons
endows agrin with the ability to bind heparin. Our results
(Figs. 3, 6, 8, and 9), taken together with those of previous
studies (Ferns et al., 1992, 1993; Hoch et al., 1993; O’Con-
nor et al., 1994; Ma et al., 1995; Cohen et al., 1997b; Bur-
gess et al., 1999), provide several lines of evidence that
both LN- and SN-agrin transcripts can either include or
exclude the Y and Z exons. (a) Nonneural cells, for exam-
ple in kidney or muscle, express LN-agrin but not SN-
agrin and Z2 but not Z1 agrin; this agrin is therefore LN/
Z2. (b) Likewise, the presence of both Y1 and Y2 agrin in
nonneural tissues argues for the existence of LN/Y2 and
LN/Y1 species. (c) Motoneurons express both LN and SN-
agrin and both Z1 and Z2 agrin. However, LN and Z1
agrin are required for synaptogenesis at the neuromuscu-
lar junction, whereas SN (either Z1 or Z2) and Z2 (either
SN or LN) agrin are insufficient. The simplest explanation
is that the nerve-derived organizer of postsynaptic differ-
entiation is LN/Z1 agrin. (d) RT-PCR analysis of residual
agrin in the agrinLN/LN mutant reveals both Z1 and Z2
populations. On the assumption that the residual agrin is
SN-agrin, both SN/Z1 and SN/Z2 RNAs must exist. (e)
Similar RT-PCR analysis provides evidence for SN/Y1
and SN/Y2 species. (f) The presence of abundant AChR-
clustering activity in the brains of agrinLN/LN mutants pro-
vides additional evidence for the existence of SN/Z1 agrin.
Proper agrin function requires that appropriate agrin
isoforms be expressed by specific cells and localized to
particular subcellular domains. We propose that combina-
tinatorial usage of putative transcriptional regulatory ele-
ments (that drive expression of SN and LN-agrin), NH2-
terminal sequences (that promote association with mem-
branes or BL) and alternatively spliced COOH-terminal
sequences (that regulate bioactivity) account for many as-
pects of the proper matching of localization to function.
The only proven activity of agrin in vivo is to organize
the neuromuscular junction. As discussed above, this ac-
tivity is mediated by the LN/Z1 form expressed by motor
neurons. The LN/Z2 splice form is a component of numer-
ous BLs. Our work demonstrates that agrin is not required
for the formation of these BLs, but it may have structural
or signaling roles postnatally (see Introduction). We are
presently unable to investigate such roles in vivo due to
the neonatal lethality of currently available agrin mutants.
Particularly intriguing is the possibility that SN-agrin plays
roles in the development or function of central neurons.
Several lines of evidence including the expression pattern
(Ma et al., 1995; Stone and Nikolics, 1995; Cohen et al.,
1997b) and localization (Escher et al., 1996; Mann and
Kroger, 1996; Halfter et al., 1997; Koulen et al., 1999) of
agrin suggest it is involved in interneuronal synaptogene-
sis. Furthermore, signal-transducing receptors for agrin
appear to be present on cultured neurons (Ji et al., 1998;
Hilgenberg et al., 1999; see also Martin and Sanes, 1997).
Two studies of cultured neurons have failed to demon-
strate roles for agrin in neuron–neuron synaptogenesis (Li
et al., 1999; Serpinskaya et al., 1999) but a third study has
reported that agrin antisense oligodigonucleotides inhibit
synapse formation (Ferreira, 1999). Unfortunately, as for
BL, subtle or postnatal roles of agrin in brain have not
been testable in vivo, owning to neonatal lethality. Be-
cause most of the agrin in central neurons is SN-agrin,
whereas motoneuronal agrin is largely of the LN isoform,
selective elimination of the SN exon may provide a suit-
able strategy for studying roles of agrin in the brain.
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